TP53 and metastatic melanoma: Thus, there is evidence of p53 isoform deregulation in melanoma cell lines and metastatic melanoma [17, 18], and in vitro studies suggest that p53 isoforms may affect melanoma aggressiveness and treatment response [17, 20].